The RSI Indicator for AMS moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 11 similar instances when the indicator left oversold territory. In 9 of the 11 cases the stock moved higher. This puts the odds of a move higher at 82%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for AMS just turned positive on October 27, 2026. Looking at past instances where AMS's MACD turned positive, the stock continued to rise in 31 of 47 cases over the following month. The odds of a continued upward trend are 66%.
Following a +6.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMS advanced for three days, in 127 of 200 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMS as a result. In 88 of 138 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
AMS broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AMS entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.354) is normal, around the industry mean (204.059). P/E Ratio (-4.731) is within average values for comparable stocks, (18.581). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (2.498). Dividend Yield (0.154) settles around the average of (0.091) among similar stocks. P/S Ratio (0.313) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. AMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The 10-day moving average for HCSG crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on HCSG as a result. In 61 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for HCSG just turned positive on October 06, 2026. Looking at past instances where HCSG's MACD turned positive, the stock continued to rise in 31 of 44 cases over the following month. The odds of a continued upward trend are 70%.
HCSG moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +16.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCSG advanced for three days, in 196 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 119 of 177 cases where HCSG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCSG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
HCSG broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.511) is normal, around the industry mean (204.059). P/E Ratio (15.341) is within average values for comparable stocks, (18.581). Projected Growth (PEG Ratio) (1.359) is also within normal values, averaging (2.498). Dividend Yield (0.032) settles around the average of (0.091) among similar stocks. P/S Ratio (0.840) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. HCSG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 39 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCSG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
AMS | HCSG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 3 | 20 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 16 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 84 | |
SMR RATING 1..100 | 93 | 39 | |
PRICE GROWTH RATING 1..100 | 78 | 37 | |
P/E GROWTH RATING 1..100 | 27 | 91 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMS's Valuation (4) in the Medical Or Nursing Services industry is in the same range as HCSG (16) in the Servicestothe Health Industry industry. This means that AMS’s stock grew similarly to HCSG’s over the last 12 months.
HCSG's Profit vs Risk Rating (84) in the Servicestothe Health Industry industry is in the same range as AMS (100) in the Medical Or Nursing Services industry. This means that HCSG’s stock grew similarly to AMS’s over the last 12 months.
HCSG's SMR Rating (39) in the Servicestothe Health Industry industry is somewhat better than the same rating for AMS (93) in the Medical Or Nursing Services industry. This means that HCSG’s stock grew somewhat faster than AMS’s over the last 12 months.
HCSG's Price Growth Rating (37) in the Servicestothe Health Industry industry is somewhat better than the same rating for AMS (78) in the Medical Or Nursing Services industry. This means that HCSG’s stock grew somewhat faster than AMS’s over the last 12 months.
AMS's P/E Growth Rating (27) in the Medical Or Nursing Services industry is somewhat better than the same rating for HCSG (91) in the Servicestothe Health Industry industry. This means that AMS’s stock grew somewhat faster than HCSG’s over the last 12 months.
| AMS | HCSG | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 82% | 1 day ago 83% |
| Stochastic ODDS (%) | 1 day ago 81% | 1 day ago 83% |
| Momentum ODDS (%) | 1 day ago 64% | 1 day ago 73% |
| MACD ODDS (%) | 1 day ago 66% | 1 day ago 70% |
| TrendWeek ODDS (%) | 1 day ago 62% | 1 day ago 65% |
| TrendMonth ODDS (%) | 1 day ago 65% | 1 day ago 66% |
| Advances ODDS (%) | 9 days ago 63% | 14 days ago 68% |
| Declines ODDS (%) | 3 days ago 64% | 9 days ago 75% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 83% |
| Aroon ODDS (%) | 1 day ago 67% | 1 day ago 67% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMS’s FA Score shows that 2 FA rating(s) are green while HCSG’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMS’s TA Score shows that 4 TA indicator(s) are bullish while HCSG’s TA Score has 6 bullish TA indicator(s).
AMS (@Hospital/Nursing Management) experienced а -7.52% price change this week, while HCSG (@Hospital/Nursing Management) price change was +10.31% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +2.93%. For the same industry, the average monthly price growth was +7.52%, and the average quarterly price growth was +16.79%.
AMS is expected to report earnings on Nov 12, 2026.
HCSG is expected to report earnings on Feb 17, 2027.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor tells us that AMS and BKD have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMS and BKD's prices will move in lockstep.
| Ticker / NAME | Correlation To AMS | 1D Price Change % | ||
|---|---|---|---|---|
| AMS | 100% | N/A | ||
| BKD - AMS | 23% Poorly correlated | +7.91% | ||
| PNTG - AMS | 21% Poorly correlated | +6.92% | ||
| ADUS - AMS | 15% Poorly correlated | +1.10% | ||
| HCA - AMS | 14% Poorly correlated | +10.34% | ||
| HCSG - AMS | 11% Poorly correlated | +3.79% | ||
More | ||||
A.I.dvisor indicates that over the last year, HCSG has been loosely correlated with NHC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HCSG jumps, then NHC could also see price increases.
| Ticker / NAME | Correlation To HCSG | 1D Price Change % | ||
|---|---|---|---|---|
| HCSG | 100% | +3.79% | ||
| NHC - HCSG | 46% Loosely correlated | +3.19% | ||
| ADUS - HCSG | 32% Poorly correlated | +1.10% | ||
| THC - HCSG | 32% Poorly correlated | +9.58% | ||
| CON - HCSG | 31% Poorly correlated | +8.49% | ||
| GRDN - HCSG | 29% Poorly correlated | +2.99% | ||
More | ||||